North America Contract Research Organization Services Market Size to Gain USD 54.01 Billion by 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on North America Contract Research Organization Services Market

5.1. COVID-19 Landscape: Contract Research Organization (CROs) Services Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. North America Contract Research Organization Services Market, By Service Type

8.1. North America Contract Research Organization Services Market, by Service Type

8.1.1 Drug Discovery

8.1.1.1. Market Revenue and Forecast

8.1.2. Preclinical Studies

8.1.2.1. Market Revenue and Forecast

8.1.3. Phase I

8.1.3.1. Market Revenue and Forecast

8.1.4. Phase II

8.1.4.1. Market Revenue and Forecast

8.1.5. Phase III

8.1.5.1. Market Revenue and Forecast

8.1.6. Phase IV

8.1.6.1. Market Revenue and Forecast

8.1.7. Others

8.1.7.1. Market Revenue and Forecast

Chapter 9. North America Contract Research Organization Services Market, By Application

9.1. North America Contract Research Organization Services Market, by Application

9.1.1. Oncology

9.1.1.1. Market Revenue and Forecast

9.1.2. Cardiology

9.1.2.1. Market Revenue and Forecast

9.1.3. Infectious Disease

9.1.3.1. Market Revenue and Forecast

9.1.4. Metabolic Disorders

9.1.4.1. Market Revenue and Forecast

9.1.5. Others

9.1.5.1. Market Revenue and Forecast

Chapter 10. North America Contract Research Organization Services Market, By End User

10.1. North America Contract Research Organization Services Market, by End User

10.1.1. Pharmaceutical & Biotechnological Companies

10.1.1.1. Market Revenue and Forecast

10.1.2. Medical Device Companies

10.1.2.1. Market Revenue and Forecast

10.1.3. Academic & Research Institutes

10.1.3.1. Market Revenue and Forecast

10.1.4. Others

10.1.4.1. Market Revenue and Forecast

Chapter 11. North America Contract Research Organization Services Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Service Type

11.1.2. Market Revenue and Forecast, by Application

11.1.3. Market Revenue and Forecast, by End User

Chapter 12. Company Profiles

12.1. BIO Agile Therapeutics

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Novotech Health Holding

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Parexel International

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Firma Clinical Research

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Charles River Laboratories

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Axcent Advanced Analytics

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Geneticist In.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Dove Quality Solutions

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Frontage Holding Corporation

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. WuXi AppTec

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The North America contract research organization services market size is expected to increase from USD 26.95 billion in 2025 to USD 54.01 billion by 2035.

Answer : The North America contract research organization services market is expected to grow at a compound annual growth rate (CAGR) of around 7.20% from 2026 to 2035.

Answer : The major players in the North America contract research organization services market include BIO Agile Therapeutics, Novotech Health Holding, Parexel International, Firma Clinical Research, Charles River Laboratories, Axcent Advanced Analytics, Geneticist In., Dove Quality Solutions, Frontage Holding Corporation, WuXi AppTec.

Answer : The driving factors of the North America contract research organization services market are the an R&D in pharmaceuticals and biotechnology spending, the growing complexity of clinical trials, the increasing prevalence of chronic diseases, and a strong trend towards outsourcing drug development to save costs and speed up market entry.